Recombinant human insulin (SciGen)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human insulin (SciGen)
Drug Alias Name重组人胰岛素 (SciGen)Recojet
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2004/12/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGenerex Biotechnology Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A